ARYA Sciences Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $143.75M |
|---|---|
| IPO Date | Oct 5, 2018 |
| CEO | Adam Stone |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Immatics Biotech |
| Deal Announced | Mar 17, 2020 |
| Deal Size, $M | $314.85M |
| Deal Sector | Healthcare |
| Deal Geography | Europe |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jun 29, 2020 |
| Amendment Vote | TBD |
| Closing Date | Jul 1, 2020 |
Formerly ARYA
IMTX
IMTXW
| Price | $4.87 |
|---|---|
| Last closing price | $4.77 |
| H/L, today | $4.69 / $4.90 |
| H/L, 52-week | $5.90 / $13.14 |
| Volume, today | 314,108 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.